Clincosm LogoSign in Get a demo

uterine cancer

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing

Not yet recruiting
  • Abnormal Uterine Bleeding
  • +7 more
  • Closure of the Vaginal Cuff after Total Hysterectomy
  • Frankfurt/Main, Hessen, Germany
  • +1 more
Sep 5, 2023

Insights Into Participating in Studies for Uterine Cancer

Not yet recruiting
  • Uterine Cancer
    • San Francisco, California
      Power Life Sciences
    Aug 11, 2023

    Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (FAST Intervention)

    Not yet recruiting
    • Ovary Cancer
    • +2 more
    • FAST Intervention
    • Chicago, Illinois
      Northwestern Memorial Hospital
    Aug 4, 2023

    Trans-Rectal Ultrasound of Female Pelvis for Real-Time MRI-US

    Not yet recruiting
    • Uterine Cancer
    • Transrectal ultrasound (TRUS)
    • Durham, North Carolina
      Duke Cancer Center
    Jul 28, 2023

    A Retrospective Study on Multiple Classifier Endometrial Cancer

    Recruiting
    • Uterine Cancer
    • Observation only
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jul 27, 2023

    Cancer, Breast, Cancer Colorectal, Cancer, Ovarian Trial in Birmingham (Proactive Cost of Care (P-COC) intervention, Usual Care)

    Recruiting
    • Cancer, Breast
    • +5 more
    • Proactive Cost of Care (P-COC) intervention
    • Usual Care
    • Birmingham, Alabama
      O'Neal Comprehensive Cancer Center
    Jun 30, 2023

    Uterine Cancer Trial in Philadelphia (18F-Fluoroestradiol)

    Not yet recruiting
    • Uterine Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 21, 2023

    Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

    Recruiting
    • Solid Tumor, Adult
    • +19 more
    • Irving, Texas
    • +2 more
    May 24, 2023

    oncRNA Stratification of Cancer by Size and Stage

    Not yet recruiting
    • Kidney Cancer
    • +32 more
    • Exai oncRNA blood test
    • (no location specified)
    Apr 27, 2023

    Cervical Cancer, Uterine Cancer Trial (Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT))

    Not yet recruiting
    • Cervical Cancer
    • Uterine Cancer
    • Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
    • (no location specified)
    Feb 24, 2023

    Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (Fit4Treatment)

    Not yet recruiting
    • Ovary Cancer
    • +6 more
    • Fit4Treatment
    • Chicago, Illinois
      Northwestern University
    Feb 21, 2023

    Adherence and Compliance to ERAS in Gynecological Surgery

    Not yet recruiting
    • ERAS
    • +7 more
    • Assessment of compliance to ERAS.
    • Brescia, BS, Italy
      Federico Ferrari
    Feb 13, 2023

    Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

    Not yet recruiting
    • Cancer
    • +16 more
    • KVA12123 - Dose Escalation
    • +3 more
    • (no location specified)
    Feb 2, 2023

    Lung Cancer, Ovarian Cancer, Uterine Cancer Trial in United States (OmniSeq Test)

    Recruiting
    • Lung Cancer
    • +12 more
    • OmniSeq Test
    • Fort Payne, Alabama
    • +7 more
    Jan 16, 2023

    Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

    Not yet recruiting
    • Gynecologic Cancer
    • +3 more
    • Cabo + Dostarlimab
    • Birmingham, Alabama
      O'Neal Comprehensive Cancer Center at UAB
    Jan 10, 2023

    Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)

    Recruiting
    • Colitis
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 17, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

    Recruiting
    • Endometrial Cancer
    • Uterine Cancer
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Sep 27, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

    Available
    • Esophageal Neoplasm
    • +9 more
    • Birmingham, Alabama
    • +3 more
    Aug 24, 2022

    Breast Cancer and Other Gynecologic Malignancies

    Enrolling by invitation
    • Breast Cancer
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 18, 2022

      Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

      Active, not recruiting
      • Melanoma
      • +9 more
      • MRx0518 Capsules
      • MRx0518/placebo Capsules
      • London, United Kingdom
        Imperial College Healthcare NHS Trust
      Aug 10, 2022

      Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer Trial in New Brunswick (Informational intervention, survey

      Recruiting
      • Gynecologic Cancer
      • +5 more
      • Informational intervention
      • survey administration
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Jul 27, 2022

      Breast Cancer, Uterine Cancer, Ovarian Cancer Trial in Denmark, France, Spain (GEN1047 is a bispecific antibody that induces

      Recruiting
      • Breast Cancer
      • +3 more
      • GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
      • Copenhagen, Denmark
      • +5 more
      Jul 25, 2022

      Uterine Cancer Trial in Boston (AZD1775)

      Recruiting
      • Uterine Cancer
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jul 5, 2022